Evaluating the Outcome of Uterine Artery Embolization in the Treatment of Submucosal Fibroid Disease

Introduction: UAE is an established procedure offered to treat patients with fibroid-related symptoms. There are recognized complications of UAE, particularly in patients with submucosal fibroids. The aim of this retrospective study is to evaluate the efficacy of UAE in patients with submucosal fibroids.

Method(s): A retrospective analysis of all patients who underwent UAE between January 1, 2017 and December 31, 2021 was performed. Pre- and postembolization MRI studies were reviewed to identify patients who had submucosal fibroid disease. Patient's details as well as uterine size, volume, and length of most dominant submucosal fibroid were analyzed in both pre- and postembolization MRI. Clinical notes and clinic letters were reviewed to determine the outcomes of UAE including complications.

Result(s): A total of 146 patients with submucosal fibroids present on their preprocedure MRI underwent UAE. Of these, 118 patients (80.8%) were satisfied with their result and were discharged from the Gynecology clinic. Remainder of the patients (28) either opted for a hysterectomy/myomectomy/TCRF or required a repeat UAE.

Conclusion(s): UAE is an effective treatment option for patients with fibroid-related symptoms. In particular, our results demonstrate it plays an integral part of successful treatment for submucosal fibroids.

Publication History

Article published online:
09 February 2023